La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Dr. Hönle Gestion
Gestion contrôle des critères 0/4
Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.
Informations clés
Markus Arendt
Directeur général
n/a
Rémunération totale
| Pourcentage du salaire du PDG | n/a |
| Durée du mandat du directeur général | less than a year |
| Propriété du PDG | n/a |
| Durée moyenne d'occupation des postes de direction | pas de données |
| Durée moyenne du mandat des membres du conseil d'administration | 2yrs |
Mises à jour récentes de la gestion
Recent updates
The Price Is Right For Dr. Hönle AG (ETR:HNL) Even After Diving 26%
Sep 26
Why Investors Shouldn't Be Surprised By Dr. Hönle AG's (ETR:HNL) P/S
Aug 06Is There An Opportunity With Dr. Hönle AG's (ETR:HNL) 50% Undervaluation?
Jul 02Dr. Hönle AG's (ETR:HNL) Popularity With Investors Is Clear
Feb 08We Think Dr. Hönle (ETR:HNL) Has A Fair Chunk Of Debt
Oct 11Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?
Aug 07Is Dr. Hönle (ETR:HNL) A Risky Investment?
Jun 03The Returns On Capital At Dr. Hönle (ETR:HNL) Don't Inspire Confidence
Nov 03Dr. Hönle (ETR:HNL) Has No Shortage Of Debt
Sep 29There Are Reasons To Feel Uneasy About Dr. Hönle's (ETR:HNL) Returns On Capital
Jul 06Capital Allocation Trends At Dr. Hönle (ETR:HNL) Aren't Ideal
Feb 20Dr. Hönle AG (ETR:HNL) Shares Could Be 37% Below Their Intrinsic Value Estimate
Jul 15Is Dr. Hönle (ETR:HNL) A Risky Investment?
Jun 14Is Dr. Hönle AG (ETR:HNL) Potentially Undervalued?
May 30Dr. Hönle (ETR:HNL) Could Be Struggling To Allocate Capital
May 17Calculating The Fair Value Of Dr. Hönle AG (ETR:HNL)
Mar 29Do Investors Have Good Reason To Be Wary Of Dr. Hönle AG's (ETR:HNL) 1.0% Dividend Yield?
Mar 16We Think Dr. Hönle (ETR:HNL) Is Taking Some Risk With Its Debt
Mar 03Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?
Feb 20
We Wouldn't Rely On Dr. Hönle's (ETR:HNL) Statutory Earnings As A Guide
Feb 08Did Business Growth Power Dr. Hönle's (ETR:HNL) Share Price Gain of 131%?
Jan 25Should We Be Excited About The Trends Of Returns At Dr. Hönle (ETR:HNL)?
Jan 11What Kind Of Investors Own Most Of Dr. Hönle AG (ETR:HNL)?
Dec 27Dr. Hönle AG (ETR:HNL) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Dec 15Is Dr. Hönle AG (ETR:HNL) An Attractive Dividend Stock?
Dec 03These 4 Measures Indicate That Dr. Hönle (ETR:HNL) Is Using Debt Extensively
Nov 22PDG
Markus Arendt
less than a year
Titularisation
Dr. Markus Arendt is Managing Director and Chairman of the Management Board of Dr. Hönle AG from May 01, 2024 and serves as its Chief Executive Officer since 2024.
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Chairman of Supervisory Board | less than a year | €379.40k | pas de données | |
| Independent Deputy Chairman of Supervisory Board | 9.6yrs | €30.00k | pas de données | |
| Independent Member of Supervisory Board | 3.4yrs | €30.00k | pas de données | |
| Supervisory Board Member | less than a year | €43.00k | pas de données | |
| Independent Member of Supervisory Board | no data | pas de données | pas de données |
2.0yrs
Durée moyenne de l'emploi
56yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de HNL ne sont pas considérés comme expérimentés (ancienneté moyenne 1.8 ans), ce qui suggère un nouveau conseil d'administration.